Whitepaper: SaaS Transition- Model N Cloud Strategic Benefits
Pharmaceutical and Medical Technology companies are seeing increased competition and regulatory demands. These dynamics appear in changes to business models, new and increased requirements, and high-velocity M&A. Adapting to these changes can be difficult when the time and costs required to keep pace are outside an organization’s core competency.
Download this whitepaper to learn how Hobson & Company, a research firm which focuses on Total Cost of Ownership (TCO) studies, worked with Model N to help quantify the typical areas and magnitude of spend an organization incurs in managing the on-premise system in order to expose the breadth of cost areas that should be considered when evaluating a possible move to the cloud.